Sep 2026· Journal of Intelligent Medicine· 0 citations· 35 references
TL;DR
The research progress of CRC heterogeneity is summarized, the development direction of multiomics integration and combination with artificial intelligence technology is outlined, and the research hotspots of immunotherapy and the tumor microenvironment are explored.
Abstract
Bioinformatics and omics have been extensively applied in colorectal cancer (CRC) research, contributing to significant scientific advances. We conducted a dual bibliometric analysis integrating overall trends with influential literature to identify major developments and emerging directions in the field. This study retrieved bioinformatics and omics‐related articles in the field of CRC from the Web of Science Core Collection from 2004 to 2025 and the top 100 most cited publications. Using SCImago Graphica, VOSviewer, CiteSpace, and RStudio, we analyzed and visualized data on countries/regions, institutions, journals, authors, citations, references, and keywords. After restriction and manual screening, 5129 publications met our criteria. The publication output has steadily increased. China and the USA led in output, international collaboration, and institutional contributions. Keyword clustering and burst analyses highlight advancements and prospects, with burst detection indicating that topics related to machine learning and immunotherapy are emerging as key research areas. We conducted a dual bibliometric analysis of bioinformatics and omics in CRC. This study summarized the research progress of CRC heterogeneity, outlined the development direction of multiomics integration and combination with artificial intelligence technology, and explored the research hotspots of immunotherapy and the tumor microenvironment.
This bibliometric analysis systematically maps the evolving research landscape of single-cell RNA sequencing (scRNA-seq) in liver cancer (LC). It summarizes global publication trends, identifies key contributors and collaborative networks, and trace the development of research hotspots over time. Publications related t...
Yi Zheng, Qian-rong Wang, Qiong Zhang et al.· Holistic Integrative Oncolog...· 1 citation
Overall, PRMTs and cancer research represents a promising research direction, and members of the PRMT family have potential utility as cancer biomarkers and therapeutic targets.
Mengjia Li, Lijing Zhan, Jinlin Cui et al.· Medicine· 0 citations
INTRODUCTION
Bladder cancer research has experienced a rapid increase in publication output with the emergence of new themes in diagnosis and treatment. The expanding literature makes it challenging to identify overarching trends and key developments. Therefore, a bibliometric analysis is warranted to systematically ev...
While molecular characterization remains foundational, AML RNA-seq research has broadened to encompass increasingly prominent cellular, functional, computational, and translational dimensions.
Yu-Ye Ren, Jiao Ma, Wen-Ya Hu et al.· Frontiers in Medicine· 0 citations
Objectives Cancer immunotherapy has achieved remarkable clinical success; however, therapeutic resistance remains a major challenge. Increasing evidence suggests that gut microbiota-derived metabolites play a critical role in modulating host immune responses and influencing treatment outcomes. This study aimed to syste...
Ying-Ying Hu, Chen-Huai Teng, Dian Zhang· Frontiers in Cellular and In...· 0 citations
The field shows rapid expansion with a China–USA dual research high-output research pattern, shifting toward microbial metabolites and microbiota-targeted immunotherapy, and future advances rely on causal mechanism verification, large-scale clinical trials and strengthened international collaboration.
Cheng-Pu Zhao, Xiang-Chen Hu· Journal of Hepatocellular Ca...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.